In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, ASLAN Pharmaceuticals Ltd ADR (NASDAQ: ASLN) closed at $0.46 down -11.13% from its previous closing price of $0.51. In other words, the price has decreased by $-11.13 from its previous closing price. On the day, 11.35 million shares were traded. ASLN stock price reached its highest trading level at $0.6121 during the session, while it also had its lowest trading level at $0.43.
Ratios:
For a deeper understanding of ASLAN Pharmaceuticals Ltd ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 1.84.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on July 09, 2021, initiated with a Buy rating and assigned the stock a target price of $8.
On January 14, 2019, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $12 to $8.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASLN now has a Market Capitalization of 10295194 and an Enterprise Value of 295196288. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67. Its current Enterprise Value per Revenue stands at 24.6 whereas that against EBITDA is -6.754.
Stock Price History:
Over the past 52 weeks, ASLN has reached a high of $4.69, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is -25.30%, while the 200-Day Moving Average is calculated to be -62.50%.
Shares Statistics:
For the past three months, ASLN has traded an average of 988.34K shares per day and 1272270 over the past ten days. A total of 17.60M shares are outstanding, with a floating share count of 16.99M. Insiders hold about 3.48% of the company’s shares, while institutions hold 19.79% stake in the company. Shares short for ASLN as of 1711584000 were 116785 with a Short Ratio of 0.12, compared to 1709164800 on 19330. Therefore, it implies a Short% of Shares Outstanding of 116785 and a Short% of Float of 0.52.
Earnings Estimates
The stock of ASLAN Pharmaceuticals Ltd ADR (ASLN) is currently drawing attention from Asana, Inc. analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $15.18, with high estimates of $79.12 and low estimates of $0.46.
